PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - 8-K Filing

Pacific Biosciences' stockholders approved an amendment to its 2020 Equity Incentive Plan on June 3, 2026, increasing the number of shares available for issuance by 16 million. The vote was part of the annual meeting where four directors were elected and other proposals ratified. (Items: 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFI, 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS, 9.01 FINANCIAL STATEMENTS AND EXHIBITS)

SEC EDGAR ·

Tickers: $PACB

Read the full article at SEC EDGAR

More Regulatory news